Trial Profile
An Open Study To Estimate The Plasma Pharmacokinetics Of PF-04764793 Administered Via Oral Inhalation Using Dry Powder Inhalers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Aug 2016
Price :
$35
*
At a glance
- Drugs PF 4764793 (Primary) ; Charcoal
- Indications Asthma
- Focus Pharmacokinetics
- Sponsors Pfizer
- 09 Dec 2009 Trial location Singapore identified as reported by ClinicalTrials.gov.
- 09 Dec 2009 Trial location Singapore identified as reported by ClinicalTrials.gov.
- 09 Nov 2009 New trial record